Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR
  • India

    COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR

    Ramya Patelkhana
    Written by
    Ramya Patelkhana
    Mail
    Last updated on Nov 13, 2020, 12:32 am
    COVISHIELD vaccine could be realistic solution to COVID-19 pandemic: ICMR
    Credits:
  • The Indian Council of Medical Research (ICMR) and Pune-based Serum Institute of India (SII) on Thursday announced the completion of enrollment of participants to the Phase-3 clinical trials for the potential COVID-19 vaccine COVISHIELD in India.

    The country's apex health research body also said that the COVISHIELD vaccine could be "a realistic solution to the deadly pandemic."

    Here are more details.

  • In this article
    Here's what Pune-based SII posted on Twitter COVISHIELD Phase 2/3 trials ongoing at 15 centers in India COVISHIELD, most advanced vaccine in human testing in India: ICMR COVISHIELD developed with master seed from Oxford University/AstraZeneca 'ICMR played huge role in strengthening India's fight against COVID-19' 'Chance to foster structural reforms in building robust public healthcare' India plays prominent role in vaccine development, manufacturing: ICMR Director-General
  • Twitter Post

    Here's what Pune-based SII posted on Twitter

  • SII has announced the completion of enrolment of Phase III clinical trials for COVISHIELD vaccine in India, under the partnership of Serum Institute of India andIndian Council of Medical Research(ICMR).

    Read To Know More -https://t.co/0NrpTjjOXx pic.twitter.com/apI5T9DroD

    — SerumInstituteIndia (@SerumInstIndia) November 12, 2020
  • Clinical trials

    COVISHIELD Phase 2/3 trials ongoing at 15 centers in India

    COVISHIELD Phase 2/3 trials ongoing at 15 centers in India
    Credits:
  • SII and ICMR are currently carrying out the Phase 2/3 clinical trials of COVISHIELD vaccine at 15 centers in India.

    "Based on the Phase 2/3 trial results, SII with the help of ICMR will pursue the early availability of this product for India. SII has already manufactured 40 million doses of the vaccine, under the at-risk manufacturing and stockpiling license from DCGI," said ICMR.

  • Details

    COVISHIELD, most advanced vaccine in human testing in India: ICMR

    COVISHIELD, most advanced vaccine in human testing in India: ICMR
    Credits:
  • "The promising results of the trials so far give confidence that COVISHIELD could be a realistic solution to the deadly pandemic," said ICMR.

    It added, "COVISHIELD is by far the most advanced vaccine in human testing in India."

    Notably, the country's highest medical research body has funded the clinical trial site fees for COVISHIELD, while SII has taken care of the other expenses.

  • Information

    COVISHIELD developed with master seed from Oxford University/AstraZeneca

  • To note, the COVISHIELD vaccine has been developed at the Serum Institute of India's Pune laboratory with a master seed from Oxford University/AstraZeneca. Meanwhile, the vaccine developed in the United Kingdom is undergoing efficacy trials in the UK, the US, Brazil, and South Africa.

  • Statement

    'ICMR played huge role in strengthening India's fight against COVID-19'

    'ICMR played huge role in strengthening India's fight against COVID-19'
  • "ICMR has played a huge role in coming forward and strengthening India's fight against COVID-19," said Adar Poonawalla, the CEO of the Pune-based Serum Institute of India, while talking about the association with the ICMR.

    "The collaboration will further aid us in putting India at the forefront of developing an immunogenic and efficacious vaccine," he added.

  • Quote

    'Chance to foster structural reforms in building robust public healthcare'

  • "The pandemic has presented a chance to foster structural reforms in building robust public healthcare infrastructure. The partnership (with ICMR) further testifies the importance of private-public institutes coming together in scaling up the management and containing the spread of the virus," Poonawalla said.

  • Details

    India plays prominent role in vaccine development, manufacturing: ICMR Director-General

    India plays prominent role in vaccine development, manufacturing: ICMR Director-General
  • India plays a major role in the field of vaccine development and manufacturing globally, said ICMR's Director-General, Balram Bhargava.

    Speaking about SII, he said, "Buoyed by the latest technology and well-equipped facilities, SII has continually proven its research and manufacturing prowess."

    "The partnership is our contribution to lending our expertise and support to bolster our fight against the global pandemic," he added.

  • South Africa
  • Indian Council of Medical Research
  • Oxford University
  • United Kingdom
  • United States of America
  •  
Latest News
  • 'Mission Majnu': Sidharth Malhotra sustains injury, resumes shoot post aid
    'Mission Majnu': Sidharth Malhotra sustains injury, resumes shoot post aid
    Entertainment
  • COVID-19 negative report must to visit Jagannath Temple
    COVID-19 negative report must to visit Jagannath Temple
    India
  • Maharashtra: Traders wait for respite following COVID-19 curbs
    Maharashtra: Traders wait for respite following COVID-19 curbs
    India
  • Katrina Kaif tests positive for coronavirus, in home isolation
    Katrina Kaif tests positive for coronavirus, in home isolation
    Entertainment
  • TMC candidate Sujata Mondal attacked by BJP workers, alleges party
    TMC candidate Sujata Mondal attacked by BJP workers, alleges party
    Politics
Related Timelines
  • SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    India
  • India could start 2021 with COVID-19 vaccine in hand: DCGI
    India could start 2021 with COVID-19 vaccine in hand: DCGI
    India
  • Coronavirus: Government says it doesn't plan to vaccinate entire country
    Coronavirus: Government says it doesn't plan to vaccinate entire country
    India
  • SII says Covishield 'safe' after trial participant sends legal notice
    SII says Covishield 'safe' after trial participant sends legal notice
    Science
Trending Topics
ISRO Vaccine
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Elon Musk Yoga Honda Batman
Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Apple Royal Challengers Bangalore Toyota Fashion Tips
Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar Chris Morris
Big Bang Theory X-Men TATA Royal Enfield
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021